24 March 2021

As Chief Operating and Commercial Officer, Thomas Bonnefont supervises the whole iBiopsy® Business Unit and drives the commercial strategy and market development plans for iBiopsy® products, as well as their implementation. Thomas Bonnefont comes to Median Technologies with over 20 years of global business management for Pharmaceuticals and Medical Devices, especially in the field of oncology, both in diagnostics as well as therapeutics. Most recently, Thomas was Global Commercial Vice-President at Guerbet Group where he built and expanded the Interventional Oncology franchise with a tremendous growth in the US, Asia-Pacific & EMEA regions. Previously Thomas held sales & marketing management positions within renowned organizations such as MicroPort, GE Healthcare, Laboratoires Pierre Fabre and Johnson & Johnson.